Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children

Journal of Immunology

Volumn 179, Issue 5, 2007, Pages 3171-3177

  Awomoyi, Agnes A ^a   Rallabhandi, Prasad ^a   Pollin, Toni I ^b   Lorenz, Eva ^c   Sztein, Marcelo B ^b   Boukhvalova, Marina S ^d   Hemming, Val G ^d,e   Blanco, Jorge C G ^d   Vogel, Stefanie N ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UMB   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d Virion Systems Inc   (United States)

^e UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 4; ASPARTIC ACID; THREONINE; TLR4 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE FREQUENCY; HETEROZYGOSITY; HIGH RISK INFANT; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NOSE MUCUS; NUCLEOTIDE SEQUENCE; PREMATURITY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS PNEUMONIA; CHEMISTRY; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; VIRUS INFECTION;

AMINO ACID SUBSTITUTION; ASPARTIC ACID; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; INFANT; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; THREONINE; TOLL-LIKE RECEPTOR 4;

EID: 38449087761     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.5.3171     Document Type: Article

References (56)

1. Chanock, R., B. Roizman, and R. Myers. 1957. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA), I: isolation, properties and characterization. Am. J. Hyg. 66: 281-290.
2. Shay, D. K., R. C. Holman, R. Newman, L. L. Liu, J. W. Stout, and L. J. Anderson. 1999. Bronchiolitis-associated hospitalizations among US children, 1980-1996. J. Am. Med. Assoc. 282: 1440-1446.
3. Thompson, W. W., D. K. Shay, E. Weintraub, L. Brammer, N. Cox, L. F. Andreson, and K. Fukuda. 2003. Mortality associated with influenza and respiratory syncytial virus in the United States. J. Am. Med. Assoc. 289: 179-186.
4. Graham, B. S., J. A. Rutigliano, and T. R. Johnson. 2002. Respiratory syncytial virus immunobiology and pathogenesis. Virology 297: 1-7.
5. McCarthy, A. J., H. M. Kingman, C. Kelly, G. S. Taylor, E. O. Caul, D. Grier, J. Moppett, A. B. Foot, J.M. Cornish, A. Oakhill, et al. 1999. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation. Bone Marrow Transplant. 24: 1315-1322.
6. Collins, P. L., K. McIntosh, and R. M. Chanock. 2001. Respiratory syncytial virus. In Fields Virology 4th ed., D. M. Knipe and P. M. Howley, eds. Lippincott-Raven, Philadelphia, PA, pp. 443-485.
7. The Prevent Study Group. 1997. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 99: 93-99.
8. The Impact-RSV Study Group. 1998. Palivizumab, a humanizied respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102: 531-537.
9. Blanco, J. C. G., M. Boukhvalova, L. Pletneva, G. A. Prince, and S. N. Vogel. 2004. Re-thinking respiratory syncytial virus vaccines. Recent Res. Develop. Exp. Med. 1: 121-125.
10. Vogel, S. N., K. A. Fitzgerald, and M. J. Fenton. 2003. TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol. Interventions 3: 466-477.
11. Kurt-Jones, E. A., L. Popova, L. Kwinn, L. M. Haynes, L. P. Jones, R. A. Tripp, E. E. Walsh, M. W. Freeman, D. T. Golenbock, L .J. Anderson, and R. W. Finberg. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1: 398-401.
12. Haynes, L. M., D. D. Moore, E. A. Kurt-Jones, R. W. Finberg, L. J. Anderson, and R. A. Tripp. 2001. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J. Virol. 75: 10730-10737.
13. Vogel, S. N., N. Bhat, S .T. Qureshi, and D. Malo. 1999. Genetic control of endotoxin responsiveness: the Lps gene revisited. In Endotoxin in Health and Disease. H. Brade, S. M. Opal, S. N. Vogel, and D. C. Morrison, eds. Marcel Dekker, New York, pp. 735-750.
14. Ehl, S., R. Bischoff, T. Ostler, S. Vallbracht, J. Schulte-Mönting, A. Poltorak, and M. Freudenberg. 2004. The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus. Eur. J. Immunol. 34: 1146-1153.
15. Haeberle, H. A., R. Takizawa, A. Casola, A. R. Brasier, H. J. Dieterich, N. Van Rooijen, Z. Gatalica, and R. P. Garofalo. 2002. Respiratory syncytial virus-induced activation of nuclear factor-κB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. J. Infect. Dis. 186: 1199-1206.
16. Arbour, N. C., E. Lorenz, B. C. Schutte, J. Zabner, J. N. Kline, M. Jones, K. Frees, J. L. Watt, and D. A. Schwartz. 2000. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25: 187-191.
17. Kiechl, S., E. Lorenz, M. Reindl, C. J. Wiedermann, F. Oberhollenzer, E. Bonora, J. Willeit, and D.A. Schwartz. 2002. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347: 185-192.
18. Lorenz, E., J. P. Mira, K. L. Frees, and D. A. Schwartz. 2002. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch. Intern. Med. 162: 1028-1032.
19. Tal, G., A. Mandelberg, I. Dalal, K. Cesar, E. Somekh, A. Tal, A. Oron, S. Itskovich, A. Ballin, S. Houri, et al. 2004. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J. Infect. Dis. 189: 2057-2063.
20. Groothuis, J. R., E. A. F. Simoes, M. J. Levin, C. B. Hall, C. E. Long, W. J. Rodriguez, J. Arrobio, H. C. Meissner, D. R. Fulton, R. C. Welliver, et al. 1993. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children: The Respiratory Syncytial Virus Immune Globulin Study Group. N. Engl. J. Med. 329: 1524-1530.
21. Medvedev, A. E., A. Lentschat, D. B. Kuhns, J. C. B. Blanco, C. Salkowski, S. Zhang, M. Arditi, J. I. Gallin, and S. N. Vogel. 2003. Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J. Exp. Med. 198: 521-531.
22. Allen, A., S. Obaro, K. Bojang, A. A. Awomoyi, B. M. Greenwood, H. Whittle, G. Sirugo, and M. Newport. 2003. Variation in Toll-like receptor 4 and susceptibility to group A meningococcal meningitis in Gambian children. Pediatr. Infect. Dis. J. 22: 1018-1019.
23. Yang, I. A., S. J. Barton, S. Rorke, J. A. Cakebread, T. P. Keith, J. B. Clough, S. T. Holgate, and J. W. Holloway. 2004. Toll-like receptor 4 polymorphism and severity of atopy in asthmatics. Genes Immun. 5: 41-45.
24. Ameziane, N., T. Beillat, P. Verpillat, S. Chollet-Martin, M-C. Aumont, P. Seknadji, M. Lamotte, D. Lebret, V. Ollivier, and D. de Prost. 2003. Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler. Thromb. Vasc. Biol. 23: E61-E64.
25. Agnese, D. M., J. E. Calvano, S. J. Hahm, S. M. Coyle, S. A. Corbett, S. E. Calvano, and S. F. Lowry. 2002. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis. 186: 1522-1525.
26. Read, R. C., J. Pullin, S. Gregory, R. Borrow, E. B. Kaczmarski, F. S. di Giovine, S. K. Dower, C. Cannings, and A. G. Wilson. 2001. A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J. Infect. Dis. 184: 640-642.
27. Michel, O., T. D. LeVan, D. Stern, M. Dentener, J. Thorn, D. Gnat, M. L. Beijer, P. Cochaux, P.G. Holt, and F. D. Martinez. 2003. Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings. J. Allergy Clin. Immunol. 112: 923-929.
28. Lorenz, E., M. Hallman, R. Marttilan, R. Haataja, and D. A. Schwartz. 2002. Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr. Res. 52: 373-376.
29. Zheng, S. L., K. Augustsson-Bälter, B. Chang, M. Hedelin, L. Li, H-O. Adami, J. Bensen, G. Li, J-E. Johnasson, and A. R. Turner. 2004. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the Cancer Prostate in Sweden Study. Cancer Res. 64: 2918-2922.
30. Netea, M. G., A. Hijmans, S. van Wissen, T. J. Smilde, M. D. Trip, B. J., Kullberg, T. de Boo, J. W. Van der Meer, J. J. Kastelein, and A. F. Stalenhoef. 2004. Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia. Eur. J. Clin. Invest. 34: 94-99.
31. Schmitt, C., A. Humeny, C. M. Becker, K. Brune, and A. Pahl. 2002. Polymorphisms of TLR4: rapid genotyping and reduced response to lipopolysaccharide of TLR4 mutant alleles. Clin. Chem. 48: 1661-1667.
32. Newport, M. J., A. Allen, A. A. Awomoyi, S. J. Dunstan, E. McKinney, A. Marchant, and G. Sirugo. 2004. The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia. Tuberculosis 84: 347-352.
33. Illig, T., F. Bongardt, A. Schopfer, R. Holle, S. Muller, W. Rathmann, W. Koenig, C. Meisnger, H. E. Wichmann, and H. Kolb. 2003. The endotoxin receptor TLR4 polymorphism is not associated with diabetes or components of the metabolic syndrome. Diabetes 52: 2861-2864.
34. Hang, J., W. Zhou, H. Zhang, B. Sun, H. Dai, L. Su, and D. C. Christiani. 2004. TLR4 Asp299Gly and Thr399Ile polymorphisms are very rare in the Chinese population. J. Endotoxin Res. 10: 238-240.
35. Erridge, C., J. Stewart, and I. P. Poxton. 2003. Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J. Exp. Med. 197: 1787-1791.
36. Franchimont, D., S. Vermeire, H. El Housni, M. Pierik, K. Van Steen, T. Gustot, E., Quertinmont, M. Abramowicz, A. Van Gossum, and J. Deviere. 2004. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299Gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53: 987-992.
37. Torok, H. P., J. Glas, L. Tonenchi, T. Mussack, and C. Folwaczny. 2004. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin. Immunol. 112: 85-91.
38. Okayama, N., K. Fujimura, Y. Suehiro, Y. Hamanaka, M. Fujiwara, T., Matsubara, T. Maekawa, S. Hazama, M. Oka, and H. Nohara. 2002. Simple genotype analysis of the Asp299Gly polymorphism of the Toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness. J. Clin. Lab. Anal. 16: 56-58.
39. Radstake, T. R. D., B. Franke, S. Hanssen, N. G., Netea, P. Welsing, P. Barrera, L. A. B. Joosten, P. L. C. M. van Reil, and W. B. van der Berg. 2004. The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Arthritis Rheum. 50: 999-1007.
40. Nguyen, D. P., M. Genc, S. Vardhana, O. Babula, A. Onderdonk, and S. S. Witkin. 2004. Ethnic differences of polymorphisms in cytokine and innate immune system genes in pregnant women. Obstet. Gynecol. 104: 293-300.
41. Reismann, P., C. Lichy, G. Rudofsky, P. M. Humpert, J. Genius, T. D. Si, C. Dorfer, A. J. Grau, A. Hamann, and W. Hacke. 2004. Lack of association between polymorphisms of the toll-like receptor 4 gene and cerebral ischemia. J. Neurol. 251: 853-858.
42. Genc, M. R., S. Vardhana, M. L. Delaney, A. Onderdonk, R. Tuomala, E. Norwitz, and S. S. Witkin. 2004. Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur. J. Obstet. Gynecol. Reprod. Biol. 116: 152-156.
43. Ferrand, P. E., T. Fujimoto, V. Chennathukuzhi, S. Parry, G. A. Macones, M. Sammel, H. Kuivaniemi, R. Romero, and J. F. Strauss III. 2002. The CARD15 2936insC mutation and TLR4 896 A>G polymorphism in African Americans and risk of preterm premature rupture of membranes (PPROM). Mol. Hum. Reprod. 8: 1031-1034.
44. Rallabhandi, P., J. Bell, M. S. Boukhvalova, A. Medvedev, E. Lorenz, M. Arditi, V. G. Hemming, J. C. B. Blanco, D. M. Segal, and S. N. Vogel. 2006. Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J. Immunol. 177: 322-332.
45. Bell, J. K., G. E. D. Mullen, C. A. Leifer, A. Mazzoni, D. R. Davies, and D. M. Segal. 2003. Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol. 24: 528-533.
46. Fujimoto, T., S. Yamazaki, A. Eto-Kimura, K. Takeshige, and T. Muta. 2004. The amino-terminal region of toll-like receptor 4 is essential for binding to MD-2 and receptor translocation to the cell surface. J. Biol. Chem. 279: 47431-47437.
47. Hartel, C., D. Finas, P. Ahrens, E. Kuttner, T. Schaible, D. Muller, H. Segerer, K. Albrecht, J. Moller, and K. Diedrick,. 2004. Polymorphisms of genes involved in innate immunity: association with preterm delivery. Mol. Hum. Reprod. 10: 911-915.
48. Prince, L. S., V. O. Okoh, T. O. Moninger, and S. Matalon. 2004. Lipopolysaccharide increases alveolar type II cell number in fetal mouse lungs through Toll-like receptor 4 and NF-κB. Am. J. Physiol. 287: L999-L1006.
49. Soutiere, S. E., C. G. Tankersley, and W. Mitzner. 2004. Differences in alveolar size in inbred mouse strains. Respir. Physiol. Neurobiol. 140: 283-291.
50. Sampath, V., K. Davis, A. P. Senft, T. R. Richardson, J. A. Kitzmiller, P. Y. Berclaz, and T. R. Korfhagen. 2006. Altered postnatal lung development in C3H/HeJ mice. Pediatr. Res. 60: 663-668.
51. Zhang, X., P. Shan, G. Jiang, L. Cohn, and P. J. Lee. 2006. Toll-like receptor 4 deficiency causes pulmonary emphysema. J. Clin. Invest. 116: 3050-3059.
52. Hashimoto, C., K. L. Hudson, and K. V. Anderson. 1988. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 52: 269-279.
53. Guillot, L., V. Valloy, F. X. McCormack, D. T. Golenbock, M. Chignard, and M. Si-Tahar. 2002. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J. Immunol. 168: 5989-5992.
54. Prince, L. S., H. I. Dieperink, V. O. Okoh, G. A. Fierro-Perez, and R. L. Lallone. 2005. Toll-like receptor signaling inhibits structural development of the distal fetal mouse lung. Dev. Dyn. 233: 553-561.
55. Cooke, G. S., S. Segal, and A. V. S. Hill. 2002. Letter to the editors. N. Engl. J. Med. 347: 1978.
56. Committee on Infectious Diseases and Committee on Fetus and Newborn. 2003. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 112: 1442-1446.